Cargando…

Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis

Hepatic encephalopathy (HE) is a devastating complication of cirrhosis. Data are limited regarding the incidence of and risk factors for HE among contemporary patients in the context of the shifting epidemiology of cirrhosis. We examined a 20% random sample of U.S. Medicare enrollees with cirrhosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tapper, Elliot B., Henderson, James B., Parikh, Neehar D., Ioannou, George N., Lok, Anna S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824059/ https://www.ncbi.nlm.nih.gov/pubmed/31701074 http://dx.doi.org/10.1002/hep4.1425

Ejemplares similares

The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis
por: Saleh, Zachary M., et al.
Publicado: (2021)

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
por: Tapper, Elliot B, et al.
Publicado: (2018)

Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis
por: Tapper, Elliot B., et al.
Publicado: (2022)

Contemporary management of pain in cirrhosis: Toward precision therapy for pain
por: Holman, Alexis, et al.
Publicado: (2023)

Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis
por: Foster, Chelsey, et al.
Publicado: (2020)

Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022)

Association between widespread pain and associated symptoms in patients with cirrhosis
por: Holman, Alexis, et al.
Publicado: (2023)

The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy
por: Bloom, Patricia P., et al.
Publicado: (2020)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Hepatic Encephalopathy: A Diagnosis for the Individual but an Experience for the Household
por: Louissaint, Jeremy, et al.
Publicado: (2020)

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States
por: Yang, Ming, et al.
Publicado: (2020)

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
por: Butterworth, Roger F.
Publicado: (2019)

Hepatic encephalopathy due to cardiac cirrhosis
por: Ono, Ryohei, et al.
Publicado: (2023)

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

Predictors of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sharma, Praveen, et al.
Publicado: (2010)

Chinese guidelines on management of hepatic encephalopathy in cirrhosis
por: Xu, Xiao-Yuan, et al.
Publicado: (2019)

Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
por: Ecker, Miriam Eva, et al.
Publicado: (2022)

Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
por: Shang, Ying, et al.
Publicado: (2023)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
por: Bai, Zhaohui, et al.
Publicado: (2019)

Medical malpractice claims in Hepatology: Rates, Reasons, and Results
por: Holman, Alexis, et al.
Publicado: (2023)

Profile of Hepatic Encephalopathy in Children with Cirrhosis and Response to Lactulose
por: Sharma, Praveen, et al.
Publicado: (2011)

Radiographical findings in patients with liver cirrhosis and hepatic encephalopathy
por: Elwir, Saleh, et al.
Publicado: (2016)

Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis
por: DARA, Naghi, et al.
Publicado: (2014)

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
por: Montagnese, Sara, et al.
Publicado: (2019)

Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis
por: Khodadoostan, Mahsa, et al.
Publicado: (2018)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study
por: Jepsen, Peter, et al.
Publicado: (2016)

Precipitating Factors and Treatment Outcomes of Hepatic Encephalopathy in Liver Cirrhosis
por: Poudyal, Nandu S, et al.
Publicado: (2019)

Predicting hepatic encephalopathy in patients with cirrhosis: A UK population–based study and validation of risk scores
por: Jones, Bethan I., et al.
Publicado: (2023)

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2016)

Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy
por: Khan, Abidullah, et al.
Publicado: (2016)

Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
por: Yuan, Lan-Ting, et al.
Publicado: (2018)

Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy
por: San Martín-Valenzuela, Constanza, et al.
Publicado: (2020)

Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
por: Campion, Daniela, et al.
Publicado: (2019)

Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis
por: Butterworth, Roger F.
Publicado: (2021)

Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
por: Moran, Segundo, et al.
Publicado: (2021)

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
por: Kim, Mo-Jong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1vgg4ad2lnlfjeso47tdgg6c3p